- Home
- PBBK vs CGTX Comparison
PBBK vs CGTX Comparison
Compare PBBK & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBBK
- CGTX
- Stock Information
- Founded
- PBBK 1919
- CGTX 2007
- Country
- PBBK United States
- CGTX United States
- Employees
- PBBK N/A
- CGTX N/A
- Industry
- PBBK Banks
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- PBBK Finance
- CGTX Health Care
- Exchange
- PBBK Nasdaq
- CGTX Nasdaq
- Market Cap
- PBBK 45.2M
- CGTX 53.4M
- IPO Year
- PBBK N/A
- CGTX 2021
- Fundamental
- Price
- PBBK $19.42
- CGTX $1.47
- Analyst Decision
- PBBK
- CGTX Strong Buy
- Analyst Count
- PBBK 0
- CGTX 3
- Target Price
- PBBK N/A
- CGTX $2.83
- AVG Volume (30 Days)
- PBBK 16.0K
- CGTX 7.6M
- Earning Date
- PBBK 11-12-2025
- CGTX 11-12-2025
- Dividend Yield
- PBBK N/A
- CGTX N/A
- EPS Growth
- PBBK 42.12
- CGTX N/A
- EPS
- PBBK 0.95
- CGTX N/A
- Revenue
- PBBK $13,359,000.00
- CGTX N/A
- Revenue This Year
- PBBK N/A
- CGTX N/A
- Revenue Next Year
- PBBK N/A
- CGTX N/A
- P/E Ratio
- PBBK $20.43
- CGTX N/A
- Revenue Growth
- PBBK 12.31
- CGTX N/A
- 52 Week Low
- PBBK $14.05
- CGTX $0.22
- 52 Week High
- PBBK $20.07
- CGTX $3.83
- Technical
- Relative Strength Index (RSI)
- PBBK 53.36
- CGTX 39.92
- Support Level
- PBBK $19.14
- CGTX $1.44
- Resistance Level
- PBBK $19.57
- CGTX $2.60
- Average True Range (ATR)
- PBBK 0.30
- CGTX 0.29
- MACD
- PBBK -0.08
- CGTX -0.19
- Stochastic Oscillator
- PBBK 35.37
- CGTX 3.23
About PBBK PB Bankshares Inc.
PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.